Abiraterone Acetate for Early Stage Metastatic Prostate Cancer: Patient Selection and Special Considerations
Therapeutics and Clinical Risk Management
doi 10.2147/tcrm.s159824
Full Text
Open PDFAbstract
Available in full text
Date
December 1, 2018
Authors
Publisher
Informa UK Limited